Natixis’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-300,000
Closed -$6.46M – 1226
2023
Q4
$6.46M Buy
+300,000
New +$5.53M 0.05% 273

Other funds holding TDOC

Natixis's TDOC Position: Q2 2026 in Review

Natixis opened a new position in Teladoc Health (TDOC) in Q2 2026: 158,900 shares worth $1.35M. The stake represents 0.01% of the portfolio and ranks #698 among its holdings. This is a return to the name: Natixis previously reported a position in TDOC as recently as Q4 2025.

Natixis first reported a position in TDOC in Q3 2017 and has held it in 26 quarters since. The position peaked at $56.2M in Q3 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Natixis held 158,900 shares of Teladoc Health worth $1.35M as of Q2 2026.
  • Teladoc Health was a new Natixis position in Q2 2026.
  • Teladoc Health made up 0.01% of Natixis's portfolio in Q2 2026, its #698 holding.
  • Natixis first reported a position in Teladoc Health in Q3 2017 and has held it in 26 quarters since.
  • Natixis's Teladoc Health position peaked at $56.2M in Q3 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.